Biochemical Journal · 1930 · 16 citations · 4 references
MedicineOncologyPharmacologyCancer PharmacologyEnzymologyPharmacodynamicsEnzyme InhibitionMalignant NeoplasmsLactic Acid Metabolism
FROM a chemical standpoint, the problem of cancerous growth may be con- sidered in two ways, either that disordered growth is caused by the presence of a chemical factor not present in normal tissue, or that disordered growth is caused by the absence of some factor normally present in adult tissue. The latter point of view seems, perhaps, to be the more plausible when one con- siders that, in certain respects, the metabolism of embryonic tissue and that of cancer tissue are similar [Warburg, 1924]. It seems reasonable to assume that with the development of the embryo there also develops a factor which checks certain phases of embryonic metabolism. This factor, present in normal adult tissue, would act as a growth regulator. If, in later life, the factor for any reason disappears, the tissue would again assume certain embryonic charac- teristics. In this paper experiments are described which were carried out to determine whether the addition of normal tissue extracts to cancer could change the characteristic metabolism of malignant tissue. As is well known, the work of Warburg [1923][1924][1925][1926] has shown that the most characteristic of the differences so far observed between the metabolism of cancerous tissue and that of normal tissue is the marked glycolytic power of the former. The line of experimentation followed, then, was to observe the change in glycolytic activity of cancer tissue brought about by the addition of extracts of various normal tissues.
4